PL440642A1 - Composition forming a stable monodisperse emulsion in water containing a fat-soluble active substance - Google Patents

Composition forming a stable monodisperse emulsion in water containing a fat-soluble active substance

Info

Publication number
PL440642A1
PL440642A1 PL440642A PL44064222A PL440642A1 PL 440642 A1 PL440642 A1 PL 440642A1 PL 440642 A PL440642 A PL 440642A PL 44064222 A PL44064222 A PL 44064222A PL 440642 A1 PL440642 A1 PL 440642A1
Authority
PL
Poland
Prior art keywords
fat
active substance
water containing
soluble active
composition forming
Prior art date
Application number
PL440642A
Other languages
Polish (pl)
Inventor
Paweł Mituła
Grzegorz Andrzej KIEŁBOWICZ
Tomasz Tronina
Radosław GNIŁKA
Original Assignee
Healthcann Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Healthcann Spółka Z Ograniczoną Odpowiedzialnością filed Critical Healthcann Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL440642A priority Critical patent/PL440642A1/en
Priority to PCT/PL2023/050015 priority patent/WO2023177313A1/en
Publication of PL440642A1 publication Critical patent/PL440642A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Ujawniono uniwersalne kompozycje, które posiadają łatwość emulgacji w roztworach wodnych o szerokim spektrum pH, tworzące stabilne monodyspersje dla związków lipofilowych i/lub hydrofobowych. Kompozycje mogą zwiększać biodostępność substancji aktywnych i nadają się do podaży doustnej w układach wodnych oraz wytwarzania produktów doustnych zwłaszcza kompozycji farmaceutycznych, wyrobów medycznych lub produktów spożywczych.Universal compositions are disclosed that are easily emulsified in aqueous solutions with a wide pH spectrum, forming stable monodispersions for lipophilic and/or hydrophobic compounds. The compositions can increase the bioavailability of active substances and are suitable for oral administration in aqueous systems and the production of oral products, especially pharmaceutical compositions, medical devices or food products.

PL440642A 2022-03-15 2022-03-15 Composition forming a stable monodisperse emulsion in water containing a fat-soluble active substance PL440642A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL440642A PL440642A1 (en) 2022-03-15 2022-03-15 Composition forming a stable monodisperse emulsion in water containing a fat-soluble active substance
PCT/PL2023/050015 WO2023177313A1 (en) 2022-03-15 2023-03-15 A composition forming stable monodisperse emulsions in water

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL440642A PL440642A1 (en) 2022-03-15 2022-03-15 Composition forming a stable monodisperse emulsion in water containing a fat-soluble active substance

Publications (1)

Publication Number Publication Date
PL440642A1 true PL440642A1 (en) 2023-09-18

Family

ID=86330912

Family Applications (1)

Application Number Title Priority Date Filing Date
PL440642A PL440642A1 (en) 2022-03-15 2022-03-15 Composition forming a stable monodisperse emulsion in water containing a fat-soluble active substance

Country Status (2)

Country Link
PL (1) PL440642A1 (en)
WO (1) WO2023177313A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015157455A1 (en) * 2014-04-08 2015-10-15 University Of Massachusetts Food matrices and methods of making and using
US20200246404A1 (en) * 2017-02-15 2020-08-06 Molecular Infusions, Llc Formulations
US10722465B1 (en) * 2017-12-08 2020-07-28 Quicksilber Scientific, Inc. Transparent colloidal vitamin supplement
EP3536332A1 (en) * 2018-03-07 2019-09-11 Athenion AG Krill oil for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents
US11013715B2 (en) * 2018-07-19 2021-05-25 Vertosa, Inc. Nanoemulsion hydrophobic substances
EP3843763A4 (en) * 2018-08-27 2022-06-15 Emerald Health Therapeutics Canada Inc. Improved cannabinoid bioavailability
EP3934629A4 (en) * 2019-03-04 2022-11-09 Daniel Young A product and process for a room-temperature stable, food-grade, all-natural, vegan, water-soluble, and phyto-cannabinoid/terpene/flavonoid colloidal dispersion
US20200306268A1 (en) * 2019-03-25 2020-10-01 Tempus Bio Technologies LLC Vitamin composition

Also Published As

Publication number Publication date
WO2023177313A1 (en) 2023-09-21

Similar Documents

Publication Publication Date Title
Aboalnaja et al. Utilization of nanoemulsions to enhance bioactivity of pharmaceuticals, supplements, and nutraceuticals: Nanoemulsion delivery systems and nanoemulsion excipient systems
Roy et al. Nanoemulsion-based dosage forms for the transdermal drug delivery applications: A review of recent advances
Bhatia et al. A review on multiple emulsions
PT1170003E (en) AUTO-EMULSING DRUG ADMINISTRATION SYSTEM FOR
Milutinov et al. Emulgels: Promising Carrier Systems for Food Ingredients and Drugs
Apolinario et al. Towards nanoformulations for skin delivery of poorly soluble API: What does indeed matter?
Ibrahim et al. Polymeric surfactant based etodolac chewable tablets: formulation and in vivo evaluation
US20180221427A1 (en) Transdermal formulations for delivery of capsaicinoids
Deng et al. Quality by design approach for the preparation of fat-soluble vitamins lipid injectable emulsion
ES2956507T3 (en) Krill oil for the solubilization of dietary supplements and active pharmaceutical ingredients that are poorly soluble in water
PL440642A1 (en) Composition forming a stable monodisperse emulsion in water containing a fat-soluble active substance
JP6882321B2 (en) Pharmaceutical product
CN107875117A (en) Oral drugs dispersive composition
Khuda et al. Preparation, characterization, and evaluation of physcion nanoparticles for enhanced oral bioavailability: An attempt to improve its antioxidant and anticancer potential
Hidalgo et al. The Anti-Oxidant Curcumin Solubilized as Oil-in-Water Nanoemulsions or Chitosan Nanocapsules Effectively Reduces Helicobacter pylori Growth, Bacterial Biofilm Formation, Gastric Cell Adhesion and Internalization
US11065206B2 (en) Topical formulations including lipid microcapsule delivery vehicles and their uses
MY120392A (en) A novel drug delivery system : formulation for fat-soluble drugs
JP7344641B2 (en) vitamin preparations
US10779561B2 (en) Resveratrol solubility
KR20200112919A (en) Emulsified gel composition containing diclofenac
LAL et al. DEVELOPMENT AND EVALUATION OF SELF EMULSIFIED DRUG DELIVERY SYSTEM OF EMBELIN FOR THE TREATMENT OF AMOEBIASIS
Ho et al. Preparation and in vivo pharmacokinetic evaluation of stable microemulsion system of cholecalciferol
KR20200002465A (en) Cosmetic with nanoparticles that encapsulated with whitening ingredient and preparation method thereof
AU2015202991B2 (en) Pharmaceutical composition
Kuksenok et al. Innovative Technology of the Self-Emulsifying Drug Delivery System of the Anticonvulsant Galodif